Holdings of ACUTA CAPITAL PARTNERS, LLC
22 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 85.3 % of the equity sleeve
Sector breakdown
- Health care 3.8 %
- Unattributed 96.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 97.2 %
- NL 2.8 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 21 | 120.6M $ | 97.24 % |
| 2 | NL | 1 | 3.4M $ | 2.76 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Praxis Precision Medicines Inc | 84,901 | 27.4M $ | |
| 2 | Terns Pharmaceuticals Inc | 495,772 | 26.1M $ | |
| 3 | Aadi Bioscience Inc | 3,410,402 | 11.8M $ | |
| 4 | Tango Therapeutics Inc | 441,831 | 9.2M $ | |
| 5 | Sutro Biopharma Inc | 269,425 | 6.7M $ | |
| 6 | Erasca Inc | 354,575 | 5.7M $ | |
| 7 | Surrozen Inc | 172,847 | 5M $ | |
| 8 | Ocular Therapeutix Inc | 592,108 | 5M $ | |
| 9 | Compass Therapeutics Inc | 849,076 | 4.5M $ | |
| 10 | Minerva Neurosciences Inc | 709,500 | 4.3M $ | |
| 11 | Argenx SE | 4,690 | 3.4M $ | |
| 12 | Revolution Medicines Inc | 26,069 | 2.5M $ | |
| 13 | Amylyx Pharmaceuticals Inc | 151,067 | 2.1M $ | |
| 14 | Taysha Gene Therapies Inc | 439,464 | 2M $ | |
| 15 | Ideaya Biosciences Inc | 48,234 | 1.6M $ | |
| 16 | Design Therapeutics Inc | 145,900 | 1.6M $ | |
| 17 | United Therapeutics Corp | 2,224 | 1.3M $ | |
| 18 | Entrada Therapeutics Inc | 89,358 | 1.1M $ | |
| 19 | AVALO THERAPEUTICS INC | 60,808 | 907.9K $ | |
| 20 | LB Pharmaceuticals Inc | 28,919 | 713.1K $ | |
| 21 | Maze Therapeutics Inc | 19,335 | 577.2K $ | |
| 22 | Unicycive Therapeutics Inc | 57,959 | 381.4K $ |